REQUEST A DEMO
Total
USD $0.00
Search more companies

Merck Sharp & Dohme (Malaysia) Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Merck Sharp & Dohme (Malaysia) Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Selling of pharmaceutical products purchased mainly from related companies; establish and operate a global business servicescentre rendering business process outsourcing services in finance and accounting and provision of implementation, maintenanceand technical services related to the above-mentioned services.

Headquarters
B-22-1 & B-22-2,The Ascent Paradigm,No.1, Jalan Ss7/26A, Kelana Jaya,
Petaling Jaya; Selangor; Postal Code: 47301

Contact Details: Purchase the Merck Sharp & Dohme (Malaysia) Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Merck Sharp & Dohme (Malaysia) Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Merck Sharp & Dohme (Malaysia) Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Merck Sharp & Dohme (Malaysia) Sdn. Bhd. report to view the information.
Incorporation Date:
July 14, 1980
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Merck Sharp & Dohme (Malaysia) Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
12.07%
Total operating revenue
12.07%
Operating profit (EBIT)
-70.01%
EBITDA
-62.08%
Net Profit (Loss) for the Period
-74.85%
Total assets
2.33%
Total equity
-5.86%
Operating Profit Margin (ROS)
-10.77%
Net Profit Margin
-11.07%
Return on Equity (ROE)
-32.49%
Debt to Equity Ratio
1.75%
Quick Ratio
-0.11%
Cash Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?